Post-Prostatectomy Complications (post-RP + TURP) — bleeding / stricture / incontinence / ED / lymphocele / DVT-PE / rectal injury / TURP syndrome
Encounter flow
12/12 authoredCanonical 12-phase frame with authored status for this dossier.
Frame
Adult male post-radical prostatectomy (open / laparoscopic / robotic) or TURP, any timepoint from PACU through years post-op
engine scope confirmed
Patient inputs (20)
Open vs laparoscopic vs robotic RP vs TURP; timepoint determines expected complication (AUA BPH 2021; NCCN 2023)
Cancer + pelvic surgery + immobility = high VTE risk; Caprini score (route cardio.dvt.core.v1)
Age >70 raises peri-op complication risk + functional outcome targets
Bleeding severity stratification — transfusion threshold (AUA BPH 2021)
TURP syndrome dilutional hyponatremia; route syndrome.hyponatremia.core.v1
Post-op AKI; urinary extravasation; obstructive uropathy
Post-Foley removal voiding trial; AUR detection (AUA BPH 2021)
Hemodynamic instability + bleeding → STAT OR/IR
Tachycardia + bleeding or PE (AUA BPH 2021)
Suspected lymphocele / urinoma / abscess / hematoma
Suspected anastomotic leak / rectourethral fistula
Suspected DVT — route cardio.dvt.core.v1
Suspected PE — route pulm.pe.core.v1 (Wells / PERC gate)
Anastomotic stricture / bladder neck contracture
pT stage + surgical margin + nodal status drives biochemical surveillance (PSA) cadence (NCCN 2023)
Bilateral vs unilateral vs non-nerve-sparing determines ED rehab approach (PMID 25140208)
Prior or planned salvage radiation raises stricture + UI + ED risk
Pre-op continence + SHIM baseline anchors post-op functional outcome (PMID 31059663)
Pre-op anticoag reversal; INR / aPTT / DOAC level if bleeding
PSA nadir at 6 wk per NCCN — biochemical recurrence baseline (NCCN 2023)
* = hard-required. Engine cannot meaningfully run until these are filled.
Severity triggers (11)
- informationallife_threateningTURP_syndrome_hyponatremicTURP syndrome — historic with glycine/sorbitol irrigant → dilutional hyponatremia + AMS + nausea + HTN; ROUTE syndrome.hyponatremia.core.v1; 3% saline if severe symptomatic (AUA BPH 2021)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalseverepost_op_bleedingEarly (<48h) hemorrhage requires resuscitation, transfusion, anticoag reversal, possible OR exploration or IR embolization; delayed (1-3 wk) anastomotic bleed (AUA BPH 2021)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalsevereDVT_PE_post_opDVT / PE post-pelvic cancer surgery — Wells score gate; route to real cardio.dvt.core.v1 or pulm.pe.core.v1 (ASCO/ACCP)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalsevererectal_injury_fistulaRectal injury — intra-operative recognition + repair; delayed rectourethral fistula → surgical repair, often diverting colostomyTrigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderateurethrovesical_anastomotic_strictureBladder neck contracture / urethrovesical anastomotic stricture — weeks-months later — weak stream, retention; cystoscopy diagnostic (AUA BPH 2021)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderatepost_prostatectomy_incontinencePost-RP stress UI — external sphincter / urethral hypermobility; route uro.urinary-incontinence-eval.v1 for ladder; pelvic floor PT → male sling → AUS (PMID 31059663)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderateED_post_opPost-RP ED from neurovascular bundle injury — PDE5i + VED + intracavernosal injection + implant ladder (PMID 25140208)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderatelymphocelePelvic lymphocele post-PLND — CT or US-guided drainage; sclerotherapy if persistent; infected → IV abx + drainage (AUA BPH 2021)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderateurinary_extravasationUrinary extravasation — anastomotic leak; prolonged Foley drainage; percutaneous urinoma drainage if symptomaticTrigger could not be auto-evaluated — needs clinician judgement.
- informationalmildpelvic_pain_chronicChronic post-RP pelvic / perineal pain (~5%); multimodal pain managementTrigger could not be auto-evaluated — needs clinician judgement.
- informationalmildclimacturiaClimacturia — orgasm-associated urine leakage post-RP — pelvic floor PT; condom catheter at intercourseTrigger could not be auto-evaluated — needs clinician judgement.
Workflow calculators
This dossier does not reference any calculators.
Recommended regimen
Post-RP ED ladder — PDE5i → VED → intracavernosal injection → penile implant- sildenafilfirst linePDE5_inhibitor50 mg PO PRN; titrate to 100 mg • PO • PRN before intercourse (max: 100 mg/day)triggers: post_RP_ED, nerve_sparingPDE5i for post-RP ED rehab; daily low-dose tadalafil alternative; counsel re α-blocker BP interaction (PMID 25140208)rxcui 136411
- tadalafilfirst linePDE5_inhibitor5 mg PO daily • PO • daily (max: 5 mg daily)triggers: post_RP_ED, penile_rehabDaily low-dose tadalafil for penile rehab post-RP; counsel re α-blocker BP interactionrxcui 358263
outpatient playbook — drug actions (3)
- 1. sildenafil OR tadalafilSildenafil 50-100 mg PRN; tadalafil 5 mg daily for rehab • PO • PRN or dailytrigger: Post-RP ED + nerve-sparing surgery (PMID 25140208)Penile rehab + sexual activity restoration
- 2. enoxaparin40 mg SC daily × 30 d • SC • dailytrigger: Extended VTE prophylaxis post-pelvic cancer surgery (ASCO/ACCP)Reduces VTE rate post-discharge
- 3. tamsulosin0.4 mg PO daily • PO • dailytrigger: Post-TURP voiding dysfunction (AUA BPH 2021)α-blocker for post-TURP voiding
Auto-drafted A&P note
outpatientSubjective
- Possible entry pathways: Post-radical prostatectomy follow-up visit (1 wk, 6 wk, 3 mo, 6 mo, annual) (AUA BPH 2021; NCCN prostate 2023); Post-TURP follow-up visit; Post-operative bleeding (24-48h or delayed) — hematuria / clot retention (AUA BPH 2021).
Objective
- No vitals, labs, or imaging entered for this encounter.
Assessment
**Post-Prostatectomy Complications (post-RP + TURP) — bleeding / stricture / incontinence / ED / lymphocele / DVT-PE / rectal injury / TURP syndrome** (uro.post-prostatectomy-complications.v1). Phenotype framing: Bleeding (early vs delayed), anastomotic stricture / bladder neck contracture, post-RP UI (stress), post-RP ED (nerve injury), lymphocele, DVT / PE, rectal injury / rectourethral fistula, urinary extravasation, chronic pelvic pain, climacturia, TURP syndrome Scope: Adult male post-radical prostatectomy (open / laparoscopic / robotic) or TURP, any timepoint from PACU through years post-op No severity triggers fired against current inputs.
Plan
Regimen axis: **Post-RP ED ladder — PDE5i → VED → intracavernosal injection → penile implant** — step "Tier 1 — PDE5 inhibitor + penile rehab". 1. sildenafil 50 mg PO PRN; titrate to 100 mg PO PRN before intercourse (PDE5_inhibitor, first line) — PDE5i for post-RP ED rehab; daily low-dose tadalafil alternative; counsel re α-blocker BP interaction (PMID 25140208) 2. tadalafil 5 mg PO daily PO daily (PDE5_inhibitor, first line) — Daily low-dose tadalafil for penile rehab post-RP; counsel re α-blocker BP interaction Setting playbook (outpatient) — Routine post-op follow-up at 1 wk (Foley removal), 6 wk (PSA), 3/6/12/24 mo (functional outcomes); detect and manage long-term complications 3. sildenafil OR tadalafil Sildenafil 50-100 mg PRN; tadalafil 5 mg daily for rehab PO PRN or daily — Post-RP ED + nerve-sparing surgery (PMID 25140208) (Penile rehab + sexual activity restoration) 4. enoxaparin 40 mg SC daily × 30 d SC daily — Extended VTE prophylaxis post-pelvic cancer surgery (ASCO/ACCP) (Reduces VTE rate post-discharge) 5. tamsulosin 0.4 mg PO daily PO daily — Post-TURP voiding dysfunction (AUA BPH 2021) (α-blocker for post-TURP voiding) Non-pharmacologic actions: - Pelvic floor PT referral for UI (NICE UI 2019; PMID 31059663) - VED training for ED rehab - Cystoscopy if stricture suspected (AUA BPH 2021) - Salvage radiation discussion per NCCN biochemical recurrence (NCCN 2023) - Cancer survivorship + psychosocial support AVOID / contraindication checks: - PDE5i_nitrate_contraindicated (AUA 2021) - PDE5i_alpha_blocker_BP_caution (AUA 2021) - Alprostadil_priapism_4h_seek_care (AUA 2021)
Monitoring
Regimen monitoring: - SHIM at 3 6 12 24mo (PMID 25140208) - penile rehab adherence at 3mo Setting (outpatient) monitoring: - PSA per NCCN protocol (NCCN 2023) - PVR after Foley removal and stricture intervention - UI bother score every visit (PMID 31059663) - SHIM at 3, 6, 12, 24 mo (PMID 25140208) Follow-up plan: Coordinate with oncology for biochemical surveillance per NCCN; psych support for functional outcomes; salvage radiation discussion if biochemical recurrence (NCCN 2023) - Close-out criterion: follow-up scheduled Monitoring phase: PSA per oncology protocol; PVR after intervention; UI bother score; SHIM at 3, 6, 12, 24 mo for ED rehab (PMID 25140208)
Disposition
Current setting: outpatient — Routine post-op follow-up at 1 wk (Foley removal), 6 wk (PSA), 3/6/12/24 mo (functional outcomes); detect and manage long-term complications Disposition criteria: - Stable + on ladder step → routine follow-up (NCCN 2023) - Functional outcome target achieved → annual surveillance - Refractory complication → multidisciplinary referral Escalation triggers (move to higher acuity): - Severe bleeding / hemodynamic instability → ED + STAT OR/IR (AUA BPH 2021) - Sudden chest pain / dyspnea → ED + STAT CT-PE (route pulm.pe.core.v1) - Severe hyponatremia + AMS → ED + ICU (route syndrome.hyponatremia.core.v1) - Rapid PSA rise → onc consult (NCCN 2023) - Refractory UI → uro + sling/AUS evaluation (PMID 31059663)
Earlier-Return Triggers
Return-precaution thresholds (watch for): - [LIFE_THREATENING] TURP syndrome — historic with glycine/sorbitol irrigant → dilutional hyponatremia + AMS + nausea + HTN; ROUTE syndrome.hyponatremia.core.v1; 3% saline if severe symptomatic (AUA BPH 2021) - [SEVERE] Early (<48h) hemorrhage requires resuscitation, transfusion, anticoag reversal, possible OR exploration or IR embolization; delayed (1-3 wk) anastomotic bleed (AUA BPH 2021) - [SEVERE] DVT / PE post-pelvic cancer surgery — Wells score gate; route to real cardio.dvt.core.v1 or pulm.pe.core.v1 (ASCO/ACCP)
Citations
- AUA BPH 2021 + NCCN Prostate Cancer 2023 + AUA/SUFU Incontinence + Post-RP ED rehabilitation + ASCO/ACCP VTE prophylaxis [PMID:34384237](https://pubmed.ncbi.nlm.nih.gov/34384237/) - Cited evidence (PMID 31059663) [PMID:31059663](https://pubmed.ncbi.nlm.nih.gov/31059663/) - Cited evidence (PMID 22749852) [PMID:22749852](https://pubmed.ncbi.nlm.nih.gov/22749852/) Last reconciled with current guidelines: 2026-05-30.
- AUA BPH 2021 + NCCN Prostate Cancer 2023 + AUA/SUFU Incontinence + Post-RP ED rehabilitation + ASCO/ACCP VTE prophylaxis — PMID:34384237
- Cited evidence (PMID 31059663) — PMID:31059663
- Cited evidence (PMID 22749852) — PMID:22749852